Research ArticleCancer

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases

See allHide authors and affiliations

Science Translational Medicine  21 Mar 2018:
Vol. 10, Issue 433, eaar1916
DOI: 10.1126/scitranslmed.aar1916

Article Information

vol. 10 no. 433

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication October 12, 2017
  • Resubmitted December 18, 2017
  • Accepted for publication January 19, 2018
  • .

Author Information

  1. Chun Gwon Park1,2,3,
  2. Christina A. Hartl1,
  3. Daniela Schmid1,2,
  4. Ellese M. Carmona1,2,
  5. Hye-Jung Kim1,2 and
  6. Michael S. Goldberg1,2,*
  1. 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  2. 2Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02215, USA.
  3. 3Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  1. *Corresponding author. Email: michael_goldberg1{at}dfci.harvard.edu

Altmetric

Article usage

Article usage: March 2018 to November 2020

AbstractFullPdf
Mar 201897867151257
Apr 20182810309790
May 20181156109249
Jun 201879455131
Jul 201862079122
Aug 2018307164126
Sep 201823590121
Oct 2018272120111
Nov 2018211109101
Dec 2018267120111
Jan 2019289149129
Feb 201920510294
Mar 2019207204157
Apr 20193342186
May 20197238133
Jun 20194229161
Jul 20192235147
Aug 20195178132
Sep 20190214151
Oct 20192228154
Nov 20191173112
Dec 20192222144
Jan 20202205163
Feb 202010213162
Mar 20201226158
Apr 20203228179
May 20202190151
Jun 20201163100
Jul 2020118492
Aug 20202193165
Sep 2020721294
Oct 20204236155
Nov 20203176125

Stay Connected to Science Translational Medicine

Navigate This Article